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Abstract
Background: Central bisectionectomy (resection of Couinaud segments IV, V and VIII) for malignant or
benign disease poses a technical challenge to the surgeon but if feasible, has significant benefits in terms
of conserving liver volume and options for future intervention. This study reviews a cohort of patients who
underwent this procedure; outlines the indications, optimal operative technique as well as both short- and
long-term outcomes.
Methods: A retrospective review of a prospectively maintained database was performed. Pre-operative
clinicopathological data, operative details and post-operative outcomes including overall and disease-
free survival were analysed.
Results: Between 1989 and 2009, 21 patients underwent a central bisectionectomy. All procedures were
performed for hepatocellular carcinoma (HCC). All patients underwent a R0 resection with a median
resection margin of 5 mm (1–15 mm). The 1-, 3- and 5-year disease-free survivals were 65%, 34.8% and
34.8%, and the corresponding overall survival rates were 90.5%, 66.8% and 66.8%, respectively.
Conclusion: These data support the use of a central bisectionectomy in selected cases in the man-
agement of HCC. With the use of a meticulous operative technique and adherence to surgical oncological
principles, satisfactory long-term outcomes were achievable.
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Introduction
Hepatic resection remains an important curative treatment
option for patients with hepatocellular carcinoma (HCC). With
refined surgical techniques and better peri-operative manage-
ment, liver resection has become a safer operation.1 As a result,
more extensive and complicated liver resections have been advo-
cated.A central bisectionectomy (resection of Couinaud segments
IV, V and VIII) for malignant or benign disease poses a technical
challenge to the surgeons. It is often indicated for centrally located
HCC in patients with a marginal liver volume. Recent studies have
shown the survival benefit of an anatomical resection over a non-
anatomical resection.2–4 Indeed, anatomical resections according
to the architecture of the portal vein have the potential to remove
undetected cancerous foci disseminated from the primary
tumour.5A central bisectionectomy has the dual benefits of pre-
serving the liver volume and complete oncological clearance.
Nonetheless, there is a scarcity of data in addressing the operative
technicality, post-operative and oncological outcome of this
operation. The aim of this study was to review the role of a central
bisectionectomy in the management of patients with HCC.
Methods
From January 1989 to December 2009, 1406 patients underwent
hepatic resections for HCC at the Department of Surgery
in Queen Mary Hospital. Among them, 21 patients received
hepatic resections of Couinaud’s segment 4,5 and 8 (i.e. a central
bisectionectomy) as defined by the International Hepato-
Pancreato-Biliary Association (IHPBA) classification.6 Their clin-
icopathological and peri-operative details were reviewed. The
selection criteria employed for a major hepatic resection included
Child–Pugh class A cirrhosis, a indocyanine clearance rate15%
at 15 min, a platelet count100 ¥ 109/l and the absence of ascites.
A central bisectionectomy was considered for centrally locating
the tumor when a right or left trisectionectomy would result in a
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liver remnant volume less than 30% of the estimated total liver
volume in normal liver or less than 35% in a cirrhotic liver, irre-
spective of the tumour size. The anatomical relationship of the
tumour in relation to the hepatic veins, portal veins and bile ducts
was evaluated by high-resolution computed tomography (CT).
Statistical analysis
Disease-free and overall survivals were assessed by Kaplan–Meier
methods. Continuous variables were expressed in median (range)
and compared between subgroups when appropriate using the
Mann–Whitney U-test. Categorical variables were compared
between subgroups using the chi-square test. A P-value0.05 was
considered to be significant. Statistical analysis was performed
using computer software SPSS Version 16.0 (SPSS Inc., Chicago,
IL, USA).
Operative technique
Surgical exposure is obtained via a bilateral subcostal incision
with midline sternal extension. An intra-operative ultrasonogra-
phy is performed routinely to detect any tumour invasion into the
main right and left portal veins, and if there is any additional
tumour nodule in the rest of the liver. The falciform ligament is
then divided and the suprahepatic inferior vena cava and hepatic
veins are exposed. Both the right liver and left lateral sections are
mobilized after division of the ligamentous attachments to the
diaphragm. A cholecystectomy is then performed and the cystic
duct is cannulated with a Fr3.5 Argyle infant feeding tube. Paren-
chymal transection is performed with an ultrasonic dissector
under a low central venous pressure (<5 mmHg) achieved by
intravenous fluid restriction with or without a low dose of intra-
venous frusemide (5–10 mg). An intermittent Pringle manoeuver
is applied when excessive bleeding is encountered during paren-
chymal transection. The central bisectionectomy is commenced
by dividing branches of the inflow portal pedicle to Segment 4b
that arises from right side of the falciform ligament. Once the left
Glissonian sheath comes into operative view as segment 4 is sepa-
rated away from the left lateral section, the plane of the parenchy-
mal transection turns medially and follows the anterior surface of
the left Glissonian sheath, then to the right Glissonian sheath that
contains the right anterior portal pedicle. Use of an ultrasonic
dissector facilitates exposure of the Glissonian sheath and the
hepatic veins that provide important anatomic landmark and
hence, guidance to the plane of transection. To facilitate identifi-
cation of the left Glissonian sheath, a large metal clip may be
placed in its vicinity followed by an operative cholangiography.
The right anterior Glissonian sheath is then isolated and divided.
By now, the ischaemic demarcation of the right anterior section
i.e. segment 5 and 8 becomes apparent. The plane of transection
follows the demarcation line posteriorly and cranially until the
root of middle hepatic vein is reached (Fig. 1a). A selective Pringle
manoeuver with inflow control of the right portal pedicle may
facilitate transection along the right lateral plane with preserva-
tion of perfusion to the left lateral section. The course of the right
hepatic vein is an important landmark that guides the transection
towards the inferior vena cava and the root of the middle hepatic
vein (Fig. 1b) which is divided using a vascular stapler towards the
end of the operation. Haemostasis is ensured and a bile leak test is
performed by injecting 10 ml of methylene blue solution into the
biliary tree via the cystic duct. A completion cholangiogram is
performed to confirm the patency of the right posterior duct and
the left duct. The raw surface of the liver is covered by a piece of
greater omentum and placement of an abdominal drain is con-
sidered if necessary.
Post-operative tumour surveillance and management
of recurrences
CT of the liver is performed at 1 month after resection to confirm
macroscopic tumour clearance and subsequently repeated every 3
months in the first 2 years after the resection, and every 6 months
thereafter. Blood sampling for serum alpha-fetoprotein (AFP) and
liver biochemistry are also performed at 3-monthly intervals in
the first 2 years after resections and 6monthly in subsequent years.
Intra-hepatic recurrence is defined as new lesions with a typical
contrast enhancement pattern on CT scan. Repeated resection
would be first considered providing the tumor is anatomically
resectable and the liver function is well preserved. Radiofrequency
ablation, transarterial oily chemoembolization or salvage liver
transplantation would be considered otherwise.
Results
Table 1 lists the patient and tumour characteristics of 21 central
bisectionectomies performed for HCC. All patients had Child–
Pugh Class A cirrhosis. Table 2 summarizes the intra-operative
and immediate post-operative data. A peri-operative blood trans-
fusion was required in 12 patients. Four patients developed post-
operative complications. There was one in-hospital mortality that
occurred in a 65-year-old patient who developed multi-organ
failure and succumbed on post-operative day 4 after resection of a
10-cm tumor in segment 4,5 and 8. The median duration of
hospital stay was 7 days (interquartile range 5–10).
The median tumour size was 7 cm (2.3–11). All patients under-
went a R0 resection with a median resection margin of 5 mm
(1–15).
The median follow-up was 32.3 months. The 1-, 3- and 5-year
disease-free survivals were 65%, 34.8% and 34.8% (Fig. 2), and
the corresponding overall survival rates were 90.5%, 66.8%
and 66.8%, respectively (Fig. 3). Intrahepatic recurrences were
detected in seven patients at the time of analysis. Among them,
five patients received second resections for first recurrence and
two patients received third resections for second recurrence.
Among those patients who received second resections for tumour
recurrence, three of them underwent a right posterior sectionec-
tomy for segment 7 recurrences due to adequate hypertrophy of
the left lateral section, and two patients received wedge resections
for recurrence in segments 2 and 7, respectively.
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Figure 1 (a) Magnetic resonance imaging (MRI) of a centrally located tumour in a 50-year old patient. Volumetry confirmed that an extended
right hepatectomy would leave just 24% of the liver volume remaining whereas an extended left hepatectomy would leave 32%, an
unacceptably small volume in a patient with chronic hepatitis B and early cirrhosis. (b) Operative view after a central bisectionectomy (RHV,
right hepatic vein; IVC, inferior vena cava; RPP, right posterior portal pedicle; S4P, ligated stump of segment 4 portal pedicle). (c)
Post-operative computed tomography (CT) images of the liver remnant. Note that the left lateral section has hypertrophied. (d) A solitary
intrahepatic recurrence in S7 at 7 months after the first resection; (e) further hypertrophy of left lateral section after right posterior
sectionectomy for S7 recurrence
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Table 1 The clinicopathological data of patients with a central
bisectionectomy
Age (years) 62.0 (38–72)
Gender (M/F) 19:2
Aetiology
HBsAg positivity 16
Anti-HCV positivity 2
Idiopathic 3
Pre-operative liver function reserve
Serum bilirubin (umol/l) 13 (5–23)
Serum GOT (IU/l) 47 (27–145)
Serum albumin (g/l) 43 (32–48)
Serum creatinine (mmol/l) 89 (51–114)
Platelet count ¥109/l 194 (103–282)
ICG (%) 9.9 (1.3–25.7)
Tumour characteristics
Solitary HCC 19
Portal vein invasion 6
Microvascular invasion 7
Tumour differentiation
Well differentiated 7
Moderately differentiated 9
Poorly differentiated 5
Tumour staging
AJCC TNM (7th TNM)5
Stage I 12
Stage II 3
Stage IIIA + IIIB 5
Stage IV 1
HCC, hepatocellular carcinoma.
Table 2 Intra-operative and immediate post-operative data
Length of procedure (min) 627 (240–1149)
Blood Loss (ml) 1590 (120–3750)
Complications
Chest infection 1
Pleural effusion: tapping not required 2
Pleural effusion: tapping required 1
Urinary tract infection 1
Cardiac arrhythmia 1
Liver failure 1
Renal failure 1
Others
DVT 1
Wound Infection 0
Bile leak 0
Mortality in first 30 days 1
DVT, deep vein thrombosis.
Figure 2 Disease-free survival after a central bisectionectomy
Figure 3 Overall survival after a central bisectionectomy
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Discussion
The concept of a central bisectionectomy as a technique in its own
right, which has been outlined in this paper, is not new. A number
of authors, as far back as 1972, have previously described this
procedure7,8; however, as Yanaga pointed out in a description of
the technique,9 it is not described in the Brisbane 2000 system of
nomenclature of hepatic anatomy and resections, the universal
terminology approved by the IHPBA in 2000.10
A central bisectionectomy is one of the most technically chal-
lenging procedures in a liver resection, especially for cirrhotic
livers. A genuine appreciation of the liver anatomy is imperative
to conduct this procedure safely without compromising the
oncological clearance. As this procedure is usually indicated for
patients with a marginal liver volume, failure to recognize and
safeguard the right posterior or left portal pedicle intraparenchy-
mally may lead to insufficient remnant liver volume and subse-
quently post-hepatectomy liver failure. The routine use of the
ultrasonic dissector for a parenchymal transection in the present
series facilitates exposure of the portal pedicles which are impor-
tant landmarks to guide the plane of transection. Without
adequate exposure of these important biliary and vascular ana-
tomical landmarks, the plane of transection may be easily skewed
into the right posterior section or left lateral section, hence sacri-
ficing more non-tumourous liver parenchyma. Likewise, the ana-
tomical course of a right hepatic vein provides an important
landmark to guide the parenchymal transection deep to the root
of the middle hepatic vein. Failure to establish this transection
plane could leave excessive segment 4 tissues close to the root of
the middle hepatic vein and could potentially compromise the
deep posterior and lateral resection margin in large tumours.
Conversely, a major drawback of using an ultrasonic dissector
especially for two different transection planes is the prolonged
operative time compared with other studies.11,12 Nonetheless, only
a meticulous transection permits the performance of a precise
hepatectomy that is regarded as an important technical attribute
to the feasibility of this complicated operation.
An adequate resection margin is often considered an important
surgical factor to ensure long-term disease-free survival after a
liver resection.13 However, in the setting of a central bisectionec-
tomy, the resection margin is often limited by the anatomical
boundary of the major vascular and biliary pedicle. Recent studies
have shown that a narrow resection margin may not compromise
the oncological efficacy of this operation.14,15 The findings from
the present study confirmed that in spite of a narrow resection
margin, satisfactory disease-free survival is still attainable as long
as an R0 tumour clearance is achieved.
One important finding from the present study was the high
proportion (71%) of patients amenable for a repeated resection
for post-operative tumour recurrence. A repeated resection has
been shown to be an efficacious treatment for recurrent HCC in
recent studies.16,17 The findings from the present study showed
that a completion right hepatectomy was often feasible for tumour
recurrence in the right posterior section because of left lateral
section hypertrophy (Fig. 1c–e). This illustrated the benefit of a
central bisectionectomy in the preservation of remnant liver
volume so as to enhance the opportunity for further resection if
needed.
Conclusion
Central bisectionectomy is a technically challenging operation
that demands a thorough analytical knowledge of the liver
anatomy. This study demonstrates that it is a safe and oncologi-
cally appropriate operation for centrally located HCC with satis-
factory long-term survivals, and permits repeated resections for
post-operative tumour recurrence.
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